h5G1.1-mAb
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for h5G1.1-mAb, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis [Phase 2]